Johnson & Johnson (JNJ)

165.30
-1.84(-1.10%)
After Hours
165.47
+0.17(+0.10%)
- Real-time Data
  • Volume:
    14,428,271
  • Day's Range:
    165.15 - 167.94
  • 52 wk Range:
    155.72 - 186.69
Unusual trading volume

JNJ Overview

Prev. Close
167.14
Day's Range
165.15-167.94
Revenue
94.88B
Open
167.54
52 wk Range
155.72-186.69
EPS
6.98
Volume
14,428,271
Market Cap
434.6B
Dividend (Yield)
4.52
(2.73%)
Average Volume (3m)
6,819,695
P/E Ratio
24.91
Beta
0.589
1-Year Change
-6.21%
Shares Outstanding
2,629,179,895
Next Earnings Date
17 Oct 2022
What is your sentiment on J&J?
or
Market is currently closed. Voting is open during market hours.

Johnson & Johnson News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Johnson & Johnson Analysis

Johnson & Johnson Company Profile

Johnson & Johnson Company Profile

Employees
141700

Johnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellNeutral
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellNeutral
  • Avoid loss!!! Allow a professional to manage your investment for profitable returns. I humbly recommend Douglas Troves on Face 📙 book He help me earned over £16,500 with my start up capital of £1,5000 with his daily signals and strategies. he’s God fearing and trustworthy what's 👤 App 👉+1 641 276 9476 for guide to professional trade
    0
    • Don't invest blindly in stocks or crypto when you do not have a proper guide. I lost 30k trying to trade on my own but ever since Douglas Troves stepped in, I have been making huge profits. I made over 450k since October. he is always available to tell you more about investing and give a guide on how to trade write him on Face📚book: Douglas Troves or Whats👤App➡️ +1 641 276 9476
      0
      • FDA approved finally. Few minutes ago!!!!
        0
        • What?
          0
      • Invested in J&J a couples years back and have closely followed the pharmaceutical industry. Found a company by the name of SpectrumX which has an IPO set for November. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trails for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
        0
        • To entry in Spectrum or not? What do you think?
          0
        • Checking it out looks like a good punt
          0
      • Good job JNJ. move forward bullish
        0
        • Stock split???
          0
          • Where we go next?
            0
            • AMC! But ultimately it’s your decision.
              0
          • Good buy. 0at this price
            0
            • JNJ is going to Make a strong come back tonight!
              1
              • Immediate inquiry must be done
                4